CD28 and stroke disorder: In the present study, with the use of a pharmacologic expansion of Treg, we independently confirm that Treg are strong potentiators of acute ischemic stroke.4 Superagonistic anti-CD28 antibody-induced expansion of Treg positively correlated with increased stroke size 24 hours after ischemia.